Utama › Kanser Prostat › Pennsylvania

Kajian klinikal Kanser Prostat di Pennsylvania

64 kajian untuk Kanser Prostat sedang mencari peserta di lokasi di Pennsylvania.

Bandar di Pennsylvania

Teks kajian rasmi (Bahasa Inggeris)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Abramson Cancer Center of the University of Pennsylvania, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
WellSpan York Cancer Center, York

Mengambil pesertaFasa 1/2

Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Saint Vincent Hospital, Erie
Jefferson Hospital, Jefferson Hills
Forbes Hospital, Monroeville
dan 8 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT06931340

Distance-Based Exercise to Preserve Function and Prevent Disability

UPMC Hillman Cancer Center at Butler Health System, Butler
IRMC Cancer Center, Indiana
UPMC Hillman Cancer Center - New Castle, New Castle
dan 2 lagi

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Geisinger Medical Center, Danville
dan 7 lagi

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Pocono Medical Center, East Stroudsburg
dan 8 lagi

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia

Mengambil pesertaFasa 1

Umur 18 ke atas · Lelaki · Dikemas kini 28 Sep 2026 · NCT06095089

DESTINY-PANTUMOUR04

Research Site, Philadelphia

Mengambil pesertaKajian pemerhatian

Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

MidLantic urology ( Site 0022), Bala-Cynwyd
Fox Chase Cancer Center ( Site 0076), Philadelphia

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

MidLantic urology, Bala-Cynwyd
The Centers for Advanced Urology d/b/a Keystone Urology Specialist, Lancaster

Mengambil pesertaFasa 3

Umur 18 ke atas · Lelaki · Dikemas kini 24 Sep 2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Fox Chase Cancer Center, Philadelphia

Mengambil pesertaFasa 2/3

Umur 18 hingga 100 · Lelaki · Dikemas kini 22 Sep 2026 · NCT06780670

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

University of Pittsburgh Medical Center, Pittsburgh

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07114601

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

University of Pittsburgh Medical Center, Pittsburgh

Mengambil pesertaFasa 3

Umur 18 ke atas · Lelaki · Dikemas kini 22 Sep 2026 · NCT07213674

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Research Site, Hershey
Research Site, Lancaster
Research Site, Pittsburgh

Mengambil pesertaFasa 3

Umur 18 ke atas · Lelaki · Dikemas kini 18 Sep 2026 · NCT06952803

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Philadelphia MultiService Center, Philadelphia, PA, Philadelphia

Mengambil pesertaFasa 2

Umur 18 ke atas · Lelaki · Dikemas kini 17 Sep 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia

Mengambil pesertaFasa 3

Umur 18 ke atas · Lelaki · Dikemas kini 17 Sep 2026 · NCT06925737

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

GSK Investigational Site, Philadelphia

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Lelaki · Dikemas kini 16 Sep 2026 · NCT07332455

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

Thomas Jefferson University, Philadelphia
University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh

Mengambil pesertaFasa 1

Umur 18 ke atas · Lelaki · Dikemas kini 15 Sep 2026 · NCT07493512

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

MidLantic Urology, Bala-Cynwyd

Mengambil peserta

Umur 18 ke atas · Lelaki · Dikemas kini 14 Sep 2026 · NCT06511141

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

UPMC-Heritage Valley Health System Beaver, Beaver
Carlisle Regional Cancer Center, Carlisle
Christiana Care Health System-Concord Health Center, Chadds Ford
dan 24 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Lelaki · Dikemas kini 10 Sep 2026 · NCT05946213

Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

Wellspan, Chambersburg

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06138067

A Study of Tarlatamab for People With Prostate Cancer

Thomas Jefferson University Hospital, Philadelphia

Mengambil pesertaFasa 2

Umur 18 ke atas · Lelaki · Dikemas kini 31 Ogo 2026 · NCT07111507

Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA

Penn State Cancer Institute, Hershey

Mengambil pesertaFasa 1/2

Umur 40 ke atas · Lelaki · Dikemas kini 31 Ogo 2026 · NCT06600698

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Research Site, Pittsburgh

Mengambil pesertaFasa 3

Umur 18 ke atas · Lelaki · Dikemas kini 26 Ogo 2026 · NCT07611110

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Lancaster Urology, Lancaster

Mengambil pesertaFasa 2

Umur 18 ke atas · Lelaki · Dikemas kini 24 Ogo 2026 · NCT07745361

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia

Mengambil pesertaFasa 2

Umur 18 ke atas · Lelaki · Dikemas kini 21 Ogo 2026 · NCT06844383

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Thomas Jefferson University, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh

Mengambil pesertaFasa 1

Umur 18 ke atas · Lelaki · Dikemas kini 21 Ogo 2026 · NCT04221542

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

UPMC Altoona, Altoona
UPMC-Heritage Valley Health System Beaver, Beaver
Carlisle Regional Cancer Center, Carlisle
dan 26 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Lelaki · Dikemas kini 19 Ogo 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of Pennsylvania, Perelman School of Medicine, Philadelphia
University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Penn State Milton S. Hershey Medical Center, Hershey
Thomas Jefferson University Honickman Center, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh

Mengambil pesertaFasa 1

Umur 18 hingga 100 · Lelaki · Dikemas kini 13 Ogo 2026 · NCT05519449

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Thomas Jefferson University, Philadelphia

Mengambil pesertaFasa 1

Umur 18 ke atas · Lelaki · Dikemas kini 31 Jul 2026 · NCT06613100

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Investigative Site #109, Philadelphia

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT06545942

PSMA PET Combined With MRI for the Detection of PCa

MidLantic Urology, Philadelphia

Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan

Umur 18 ke atas · Lelaki · Dikemas kini 23 Jul 2026 · NCT07052214

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Christiana Care Health System-Concord Health Center, Chadds Ford
Geisinger Medical Center, Danville
Geisinger Cancer Center Dickson City, Dickson City
dan 6 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Lelaki · Dikemas kini 14 Jul 2026 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

MidLantic Urology, Bala-Cynwyd
Keystone Urology Specialists, Lancaster

Mengambil pesertaFasa 1

Umur 18 ke atas · Lelaki · Dikemas kini 9 Jul 2026 · NCT05413421

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

Thomas Jefferson University, Philadelphia
University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh

Mengambil pesertaFasa 1

Umur 18 ke atas · Lelaki · Dikemas kini 2 Jul 2026 · NCT07140900

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Thomas Jefferson University Hospital, Philadelphia

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Lelaki · Dikemas kini 25 Jun 2026 · NCT06457919

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Corporal Michael J. Crescenz VA Medical Center, Philadelphia

Mengambil pesertaFasa 2

Umur 18 ke atas · Lelaki · Dikemas kini 15 Jun 2026 · NCT05422911

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

University of Pittsburg Medical Center (UPCM), Pittsburgh

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 11 Jun 2026 · NCT05283330

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

UPMC Hillman Cancer Center, Pittsburgh

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT04890613

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Univ of Pittsburgh Medical Center, Pittsburgh

Mengambil pesertaFasa 4

Umur 18 hingga 100 · Lelaki · Dikemas kini 4 Jun 2026 · NCT05803941

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.